$IFUS is only pink not pumping and dumping because they have
I never miss a day of taking INTACT DIGEST.
IFUS PRODUCTS SIMPLY WORK FOR YOUNG AND LOL OLDER INDIVIDUALS
That is a simple way to explain why I am invested in IFUS stock.
THE PRODUCTS WORK THEY REALLY WORK ... THE PRODUCTS WORK THEY REALLY WORK!
IFUS was started by having a unique group of products that benefited people and animals.Those products have a loyal following.
IMO,after 3-4 years of trying to get financing to Distribute IFUS products WITH NO TAKERS, Marc Walther,ceo,friend,genius,and THE "DUKE OF BAGASSE" in Napoleonville had an idea that took the product that works and combined it with bagasse to carry NUTRI-MASTIC and proprietary ingredients to livestock.
He found great financing for his idea and developed equipment and systems to create Supreme Gold Plus bagasse.
IMO,HIS GOALS AND BUSINESS PLANS ARE SIMPLY TO REVOLUTIONIZE BOTH THE LIVESTOCK AND BEVERAGE INDUSTRY WITH PRODUCTS THAT IMPROVE HEALTH OF PEOPLE OR ANIMALS THAT USE IT .
STEP NUMBER ONE
------------------------------------------------------------------
DEVELOP SALES AND DISTRIBUTORS FOR SUPREME GOLD PLUS BAGASSE
DEVELOP SALES AND DISTRIBUTION FOR INTACT NUTRITION PRODUCTS
DEVELOP SALES AND DISTRIBUTION FOR MASTIC BLAST PRODUCTS.
------------------------------------------------------------------
STEP NUMBER TWO
COMBINE WEBSITES,FACEBOOK AMAZON,ADVERTISING,MARKETING,BRANDING,
Radio,etc to increase sales and educate everyone about the products their benefits and the importance of improved health for people and livestock.
"IT is not what you eat it is what you absorb".
------------------------------------------------------------------
STEP THREE
Use the money generated to build distribution and partners to take the ingredients in blue line products and put them in a drink like Mastic blast and distribute in throughout the U.S.A.
RETHINK YOUR DRINK
-----------------------------------------------------------------
I know some IFUS shareholders think long term is a month or two.
That's ok take your profits at .02 or .03.
I have been telling everyone for 4 years that IFUS is a real company.I know it as do several other shareholders and distributors.
IFUS has unique products with high profit margins that work with both people and livestock.
I have told family and friends that IFUS pps will be much higher before Saint Patrick's Day
This is not the company, this is me saying before March 17TH both my beer and my ira will increase 5 times.
IFUS PPS WILL RISE TO MAKE EVERY SHAREHOLDER GREEN NO MATTER WHEN YOU BOUGHT.
Public Reply | Private Reply | UnKeep | Last Read
Impact Fusion International Inc (IFUS) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Community Need Drives Event Extension October in Jonesboro just got a bit more hopeful for breast cancer survivors—it's not just about awareness anymore; it's about action. The United Breast Cancer Foundation (UBCF) has decided to extend its popular Pink Bag free shopping event through October 30th. What spurred this decision? Well, the overwhelming community demand,...
Continue Reading
Mapping the Complex Maze of MicroRNA on Circular RNAs Pusan National University's brainiacs have cooked up something spicy for the bioinformatics world. They've developed this snazzy AI tool, circMAC, to unravel microRNA binding mysteries on circular RNAs. 'Why’s this such a big deal?' you ask. Well, these loop-shaped critters, circRNAs, play a backstage role in gene...
Continue Reading
A New Era for Podium When the brass at Podium made a gamble on AI, they didn't just try squeezing it into their old business model. Oh no, they launched what feels like a startup within their existing empire—no half-measures, just full-throttle ambition. Fast forward two and a half years, and they've racked up over $150 million in annual recurring revenue from these...
Continue Reading
Rethinking How We Evaluate Drug Abuse Potential Sometimes, the finance world gets a peek into something that ain't just about the numbers on a screen, something with real stakes beyond the bulls and bears. Labcorp's just thrown its hat in with the FDA and Charles River Laboratories in a collaboration that goes beyond just lining pockets. They're setting up to dissect how...
Continue Reading
Vertice Dives Deeper into the Procurement Game Grab a coffee and let's talk some procurement—one of the least sexy, yet utterly essential parts of any operation. Vertice's latest announcement is anything but mundane. They're spiraling deeper into the procurement universe with their new Procure-to-Pay (P2P) capability, a bold expansion from their Intake-to-Procure (I2P)...
Continue Reading
AI Investments Without Returns: The Current Scenario Well, wouldn't you know it? Enterprises have sunk a fortune into AI, and they're wagging their fingers once more at the mounting bills with little to show for it. Play the investment game long enough, and it seems you'll find the numbers don't always rub together and make sparks. This familiar tune of over-budget...
Continue Reading
Puerto Rico Welcomes College Football with Open Arms Imagine kicking towards the goalposts while the ocean breeze kisses your face—yep, that's what's happening in Puerto Rico this December. TransPerfect, a heavyweight in language and tech solutions, is rolling out the red carpet for the inaugural TransPerfect San Juan Bowl, and it’s not just a game. It’s a bold step...
Continue Reading
A Mighty Move in Manufacturing Carrier Global Corporation's recent muscle-flexing is something rarer than a golden goose in today's market—a $600 million thrust into beefing up U.S. manufacturing and engineering. You can't help but wonder if this is overzealous optimism or a meticulously calculated power play. Clocks don't tick this loudly without good reason, of...
Continue Reading
Innventure's Murky Waters Just when you think you've seen it all, stuff like this reminds you nothing's safe in the market. The law folks at Stranch, Jennings & Garvey, PLLC are sniffing around Innventure, Inc. (NASDAQ: INV) like bloodhounds to see if there's been some hoodwinking going on. We're talking questions about funny business with a data center deal between...
Continue Reading
The Satellite Race Heats Up: Xona's Ambitious Leap Hold onto your hats, folks, because Xona's making headlines with a $250 million infusion. This ain't just pocket change—it's part of a rocket-fueled mission to upend the GPS landscape. Imagine a world where GPS is 100 times stronger. That's the pitch, and folks, it's got the market buzzing. Valuation Rocketing: Investor...
Continue Reading
Top 5 Most Recently Viewed Articles
osapiens Secures Major Funding Round osapiens, a leading firm in enterprise software dedicated to encouraging sustainable growth, has recently announced a significant financial milestone. The company has secured an impressive US$ 100 million in a Series C funding round, spearheaded by Decarbonization Partners, a collaboration between BlackRock and Temasek. This newfound...
Continue Reading
Microsoft and Thrive Global Join Forces for Employee Wellbeing Microsoft has embarked on an inspiring journey by partnering with Thrive Global, a company that specializes in behavior change strategies aimed at enhancing overall wellbeing. This collaboration aims to integrate a range of wellbeing resources seamlessly into the daily operations of Microsoft Teams, making it...
Continue Reading
Coventry First LLC Files Motion to Dismiss Lawsuit Coventry First LLC, along with Co-Founder and Executive Chairman Alan H. Buerger, is taking a decisive stand against the lawsuit filed by Abacus Global Management, Inc. This move comes in response to a claim that Coventry believes lacks merit, particularly in light of recent industry changes. Key Developments Around the...
Continue Reading
AbbVie Declares Quarterly Dividend The board of directors at AbbVie Inc. (NYSE: ABBV) has announced a quarterly cash dividend of $1.55 per share. This decision reflects the company's ongoing commitment to providing value to its shareholders through dependable and substantial dividend distributions. Details and Timeline for the Dividend The announced dividend will be paid...
Continue Reading
GitLab's Growing Demand for 'Ultimate' GitLab Inc (NASDAQ: GTLB) has recently experienced a notable uptick in the adoption of its 'Ultimate' offering, according to industry expert insights. The stock saw a boost when analyst Mike Cikos from Needham raised its rating from Hold to Buy, setting a price target of $70. This optimistic outlook is backed by GitLab's continued...
Continue Reading